NMDA enhancer (investigational)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NMDA enhancer (investigational), covering 2021-08-26 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer [Phase 2]